Scandinavian Real Heart AB (Publ) (HEART.ST)
Scandinavian Real Heart AB (Publ) operates in the Medical - Devices industry of the Healthcare sector, headquartered in Västerås, VM, SE. The stock last traded at $17.90, down 0.28% on the session, giving a market capitalisation of $152.1M. Its beta of 1.18 implies it has historically moved more than the broad market.
Scandinavian Real Heart AB (Publ), a Swedish enterprise established in 2007, specializes in the innovation and production of artificial heart devices. The company's core focus is the Realheart TAH, a total artificial heart engineered specifically to address severe cases of heart failure. Beyond this central project, their product portfolio also encompasses medical solutions such as the RealVAD, PulsePump, and Sternal Prosthesis. The firm operates from its base in Västerås, Sweden.
Scandinavian Real Heart AB (Publ) is most often compared with the following Healthcare names: